Beta: Sign in
Shares outstandingAs of 2026-08-10 · filed common shares: 197.84M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.09%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 9.56%
Short ratioDays to cover, as published by FINRA: 3.08
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 70.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 61.50%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for ABUS

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginTTM to Jun 26: 81.99%
Net margin: —
EBITDA marginFY Dec 25: -268.39%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 89.58%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 81.13%

Growth

Revenue growth (annual YoY): 128.21%
Revenue growth (latest qtr YoY): -90.56%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): -303.84%
EPS growth (fwd): Sign in
Net income growth (QoQ): -103.03%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: 0.79
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $19.17M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $514.00K
Debt / equityas of Jun 26: 0.20%
Current ratioas of Jun 26: 81.42
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 27.64
Operating cash flowTTM to Jun 26: -$24.62M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$24.62M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.94

ABUS stock Statistics — Arbutus Biopharma Corp filings, insiders & smart money · Instaport